Analysis of the parameters tested in GC patients by grade showed a significant increase in T lymphocytes CD4+TLR-9+ and B lymphocytes CD19+TLR-9+ between G1 and G2 and G3 patients (Supplementary Materials Figure S2A–C). This evidence concerns the gene TLR9 and gastric cancer.